IP Library › Granted Patent US 8,034,946
Granted Patent B2
US 8,034,946 · App. 12/814,629 · Granted Oct 11, 2011

Biphenyl compounds useful as muscarinic receptor antagonists

Assignee: Theravance, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,946
App. No.
12/814,629
Granted
Oct 11, 2011
Kind
B2
Abstract

This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar 1 , R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , and R 8 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.

Claims (2)

1. A composition comprising the compound of formula:

2. A composition comprising a salt of the compound of formula:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 033118/0499 →
Continuity (4)
Continuation 11879835 · Jul 19, 2007
Continuation 11077433 · Mar 10, 2005
Provisional Application 60552443 · Mar 11, 2004
Related Publication 20100249421A1 · Sep 30, 2010